NIH-funded research R03 grant

Developing a peptide to help drugs cross the blood-brain barrier

Official title: Rational design and testing of blood-brain-barrier shuttle peptide

Funded at Northeast Ohio Medical University · NIH-11003722 · Data updated 2026-11-12

This study is working on a special helper that can make it easier for important medications to reach the brain, which is often tough to do for people with brain-related conditions, so they can get better treatment with fewer side effects.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionNortheast Ohio Medical University
NIH-funded
Lab location1 site (Rootstown, United States)
Project startDecember 22, 2023
Project endNovember 30, 2025
Funding year2025
Award (this year)$78,000
NIH project number5R03NS135326-02
Project IDNIH-11003722 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with neurological disorders that require effective drug therapies.

Less likely to help

Patients with conditions that do not involve the central nervous system may not benefit from this research.

What this research studies

This research focuses on creating a specialized peptide that can facilitate the transport of therapeutic drugs across the blood-brain barrier (BBB), which is a significant challenge in treating central nervous system conditions. The approach involves targeting specific receptors on the BBB to enhance drug delivery while minimizing side effects. By improving the ability of drugs to penetrate the BBB, this research aims to increase the chances of successful treatment options for patients with neurological disorders. The methodology includes designing and testing these peptides to ensure they effectively bind to the BBB receptors.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for neurological conditions by improving drug delivery to the brain.

How similar studies have gone: Previous research has shown promise in using receptor-targeted approaches to enhance drug delivery across the BBB, indicating potential for success in this area.

Where this research is happening

  • Northeast Ohio Medical University
    Rootstown, United States
    Active

Researchers

  • Principal investigator: Shin, Woo Shik — Northeast Ohio Medical University
  • Study coordinator: Shin, Woo Shik

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.